{"title":"Identification of Epigenetic Regulators of Vascular Calcification with a CRISPR-Based Screen.","authors":"Yaxin Lian,Chen Xie,Minjia Feng,Huijin Zhu,Xin Chen,Xiaolin Liu,Yun Kong,Dayu He,Jianshuai Ma,Yuxi Chen,Huanji Zhang,Aoran Huang,Yanlian Chen,Hui Huang","doi":"10.1681/asn.0000000793","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nVascular calcification, mainly driven by osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs), is a common pathological condition in patients with chronic kidney disease. However, the roles of other epigenetic regulators in this process remain largely unexplored. CRISPR screen is a highly efficient strategy widely used in identifying genes related to various biological processes. However, the lack of suitable cell sorting strategies combined with CRISPR screen meant this technology had not been applied to gene screening in vascular calcification.\r\n\r\nMETHODS\r\nWe performed an epigenetic-focused CRISPR screen in primary human VSMCs and identified key genes and pathways underlying osteogenic transdifferentiation, based on sgRNA enrichment in RANKL + (calcified) and RANKL - (noncalcified) VSMCs isolated by magnetic activated cell sorting. To validate the screen results, potential genes with different rankings were validated by siRNA intervention and Alizarin Red S staining. Integrating CRISPR results with transcriptome data revealed 17 critical regulators. We further investigated the top hit, Anthrax Toxin Receptor 1 (ANTXR1), in vascular calcification by examining clinical human samples and intervention in mice model.\r\n\r\nRESULTS\r\nThrough CRISPR screen, we identified 122 potential genes positive-regulating vascular calcification and 116 negative-regulating genes. Phenotypic experimental results further verified the roles of genes with different rankings in osteogenic transdifferentiation of VSMCs, reinforcing the validity of our CRISPR screen system. Notably, integrative analysis of CRISPR screen with transcriptome data revealed ANTXR1 as a critical factor regulating vascular calcification. Furthermore, detection of clinical human samples confirmed the upregulation of ANTXR1 during calcification. Knockdown of ANTXR1 suppressed vascular calcification in mice model; likewise, overexpression promoted vascular calcification and the osteogenic transdifferentiation of VSMCs.\r\n\r\nCONCLUSIONS\r\nOur epigenetic-focused CRISPR screen and transcriptome analysis identified critical epigenetic genes involved in vascular calcification.","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"10 1","pages":""},"PeriodicalIF":10.3000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1681/asn.0000000793","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Vascular calcification, mainly driven by osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs), is a common pathological condition in patients with chronic kidney disease. However, the roles of other epigenetic regulators in this process remain largely unexplored. CRISPR screen is a highly efficient strategy widely used in identifying genes related to various biological processes. However, the lack of suitable cell sorting strategies combined with CRISPR screen meant this technology had not been applied to gene screening in vascular calcification.
METHODS
We performed an epigenetic-focused CRISPR screen in primary human VSMCs and identified key genes and pathways underlying osteogenic transdifferentiation, based on sgRNA enrichment in RANKL + (calcified) and RANKL - (noncalcified) VSMCs isolated by magnetic activated cell sorting. To validate the screen results, potential genes with different rankings were validated by siRNA intervention and Alizarin Red S staining. Integrating CRISPR results with transcriptome data revealed 17 critical regulators. We further investigated the top hit, Anthrax Toxin Receptor 1 (ANTXR1), in vascular calcification by examining clinical human samples and intervention in mice model.
RESULTS
Through CRISPR screen, we identified 122 potential genes positive-regulating vascular calcification and 116 negative-regulating genes. Phenotypic experimental results further verified the roles of genes with different rankings in osteogenic transdifferentiation of VSMCs, reinforcing the validity of our CRISPR screen system. Notably, integrative analysis of CRISPR screen with transcriptome data revealed ANTXR1 as a critical factor regulating vascular calcification. Furthermore, detection of clinical human samples confirmed the upregulation of ANTXR1 during calcification. Knockdown of ANTXR1 suppressed vascular calcification in mice model; likewise, overexpression promoted vascular calcification and the osteogenic transdifferentiation of VSMCs.
CONCLUSIONS
Our epigenetic-focused CRISPR screen and transcriptome analysis identified critical epigenetic genes involved in vascular calcification.
期刊介绍:
The Journal of the American Society of Nephrology (JASN) stands as the preeminent kidney journal globally, offering an exceptional synthesis of cutting-edge basic research, clinical epidemiology, meta-analysis, and relevant editorial content. Representing a comprehensive resource, JASN encompasses clinical research, editorials distilling key findings, perspectives, and timely reviews.
Editorials are skillfully crafted to elucidate the essential insights of the parent article, while JASN actively encourages the submission of Letters to the Editor discussing recently published articles. The reviews featured in JASN are consistently erudite and comprehensive, providing thorough coverage of respective fields. Since its inception in July 1990, JASN has been a monthly publication.
JASN publishes original research reports and editorial content across a spectrum of basic and clinical science relevant to the broad discipline of nephrology. Topics covered include renal cell biology, developmental biology of the kidney, genetics of kidney disease, cell and transport physiology, hemodynamics and vascular regulation, mechanisms of blood pressure regulation, renal immunology, kidney pathology, pathophysiology of kidney diseases, nephrolithiasis, clinical nephrology (including dialysis and transplantation), and hypertension. Furthermore, articles addressing healthcare policy and care delivery issues relevant to nephrology are warmly welcomed.